PCVX Stock | | | USD 93.98 2.53 2.77% |
Vaxcyte financial indicator trend analysis is much more than just breaking down Vaxcyte prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Vaxcyte is a good investment. Please check the relationship between Vaxcyte Retained Earnings and its Total Liab accounts. Check out
Your Equity Center to better understand how to build diversified portfolios, which includes a position in Vaxcyte. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in real.
For more information on how to buy Vaxcyte Stock please use our
How to Invest in Vaxcyte guide.
Retained Earnings vs Total Liab
Retained Earnings vs Total Liab Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Vaxcyte Retained Earnings account and
Total Liab. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between Vaxcyte's Retained Earnings and Total Liab is -0.57. Overlapping area represents the amount of variation of Retained Earnings that can explain the historical movement of Total Liab in the same time period over historical financial statements of Vaxcyte, assuming nothing else is changed. The correlation between historical values of Vaxcyte's Retained Earnings and Total Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Retained Earnings of Vaxcyte are associated (or correlated) with its Total Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Liab has no effect on the direction of Retained Earnings i.e., Vaxcyte's Retained Earnings and Total Liab go up and down completely randomly.
Correlation Coefficient | -0.57 |
Relationship Direction | Negative |
Relationship Strength | Very Weak |
Retained Earnings
The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.
Total Liab
The total amount of all liabilities that a company has, including both short-term and long-term liabilities.
Most indicators from Vaxcyte's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Vaxcyte current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Your Equity Center to better understand how to build diversified portfolios, which includes a position in Vaxcyte. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in real.
For more information on how to buy Vaxcyte Stock please use our
How to Invest in Vaxcyte guide.
Selling General Administrative is likely to rise to about 63.7
M in 2024, whereas
Issuance Of Capital Stock is likely to drop slightly above 364.6
M in 2024.
Vaxcyte fundamental ratios Correlations
Click cells to compare fundamentals
Vaxcyte Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Vaxcyte fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Vaxcyte Stock Analysis
When running Vaxcyte's price analysis, check to
measure Vaxcyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxcyte is operating at the current time. Most of Vaxcyte's value examination focuses on studying past and present price action to
predict the probability of Vaxcyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxcyte's price. Additionally, you may evaluate how the addition of Vaxcyte to your portfolios can decrease your overall portfolio volatility.